MADD-like pattern of acylcarnitines associated with sertraline use
Multiple acyl-CoA dehydrogenase deficiency (MADD) is a primary mitochondrial dysfunction affecting mitochondrial fatty acid and protein metabolism, caused by biallelic pathogenic variants in ETFA, ETFB, or ETFDH genes. The heterogeneous phenotypes associated with MADD have been classified into three...
Автори: | Filippo Ingoglia, Mohsen Tanfous, Benjamin Ellezam, Katherine J. Anderson, Marzia Pasquali, Lorenzo D. Botto |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Elsevier
2024-12-01
|
Серія: | Molecular Genetics and Metabolism Reports |
Предмети: | |
Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2214426924000958 |
Схожі ресурси
Схожі ресурси
-
Clinical, biochemical, and genetic spectrum of MADD in a South African cohort: an ICGNMD study
за авторством: Michelle Bisschoff, та інші
Опубліковано: (2024-01-01) -
Correlation between ETFDH mutations and dysregulation of serum myomiRs in MADD patients
за авторством: Sara Missaglia, та інші
Опубліковано: (2020-03-01) -
Effects of sertraline on cognitive function in patients with unipolar depressive disorders
за авторством: R. V. Akhapkin, та інші
Опубліковано: (2018-11-01) -
MCAD-Deficiency with Severe Neonatal Onset, Fatal Outcome and Normal Acylcarnitine Profile
за авторством: Ralph Fingerhut, та інші
Опубліковано: (2017-08-01) -
Importance of acylcarnitine profile analysis for disorders of lipid metabolism in adolescent patients with recurrent rhabdomyolysis: Report of two cases
за авторством: Yasemin Topçu, та інші
Опубліковано: (2014-01-01)